Toxic Alcohols Suzanne R
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Effect of Diethylenetriamine and Triethylamine Sensitization on the Critical Diameter of Nitromethane’
CP505, Shock Compression of Condensed Matter - 1999 edited by M. D. Furnish, L. C. Chhabildas, and R. S. Hixson 0 2000 American Institute of Physics l-56396-923-8/00/$17.00 EFFECT OF DIETHYLENETRIAMINE AND TRIETHYLAMINE SENSITIZATION ON THE CRITICAL DIAMETER OF NITROMETHANE’ J.J. Lee*, J. Jiang?, K.H. Choong’, J.H.S. Lee’ *Graduate Aeronautics Laboratory, California Institute of Technology, Pasadena, CA 9112.5, USA ‘Dept. of Mechanical Engineering, McGill University, Montr&al, Que’bec, Canada, H3A 2K6 In this work, the critical diameter for detonation was measured for Nitromethane (NM) sensitized with two different amines: Diethylenetriamine (DETA) and Triethylamine (TEA). The critical diameter in glass and polyvinylchloride tubes is found to decrease rapidly as the amount of sensitizer is increased, then increase past a critical amount of sensitizer. Thus the critical diameter reaches a minimum at a critical concentration of sensitizer. It was also found that the critical diameter is lower with DETA than with TEA. INTRODUCTION propagation in various tubes and channels, and the critical conditions for propagation in porous media Previous studies have shown that small (3) . concentrations of certain substances can strongly The effect of DETA on the critical diameter of increase the explosive sensitivity nitromethane NM has been reported by Engelke (4), who (NM). Amines are found to be the most effective performed measurements with up to 2.5% DETA by chemical sensitizing agent for NM with mass in NM. Engelke observed a reduction in the ethylenediamine and diethylenetriamine (DETA) critical diameter of over 50% in the range of DETA producing the largest increase in the card gap value concentrations used. -
Preventing Inhalant Abuse
A Parent’s Guide to 800.232.4424 (Voice/TTY) 860.793.9813 (Fax) www.ctclearinghouse.org Preventing Inhalant Abuse A Library and Resource Center on Alcohol, Tobacco, Other Drugs, Mental Health and Wellness Inhalant Abuse: It's Deadly. Inhalant abuse can What are the effects of inhalant abuse? kill. Sniffing can cause sickness and death. For example, It can kill suddenly, and it can kill those who sniff for victims may become nauseated, forgetful, and unable the first time. to see things clearly. Victims may lose control of their body, including the use of arms and legs. These effects Every year, young people in this country die of can last 15 to 45 minutes after sniffing. inhalant abuse. Hundreds suffer severe consequences, including permanent brain damage, loss of muscle In addition, sniffing can severely damage many parts control, and destruction of the heart, blood, kidney, of the body, including the brain, heart, liver, kidneys, liver, nerves, and bone marrow. and nerves. Ordinary household products, which can Even worse, victims can die suddenly -- without any be safely used for legitimate purposes, warning. "Sudden Sniffing Death Syndrome" can occur can be problematic in the hands of an during or right after sniffing. The heart begins to inhalant abuser. overwork, beating rapidly but unevenly, which can lead to cardiac arrest. Even first-time abusers have Today more than 1,000 common household products been known to die from sniffing inhalants. are commonly abused. The National Institute on Drug Abuse reported that one in five American teenagers How can you tell if a young person is an inhalant have used inhalants to get high. -
Alcohol Intoxication Withdrawal Adult
Provincial Clinical Knowledge Topic Alcohol Intoxication Withdrawal, Adult Emergency Department V 1.5 © 2018, Alberta Health Services. This work is licensed under the Creative Commons Attribution-Non-Commercial-No Derivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. Disclaimer: This material is intended for use by clinicians only and is provided on an "as is", "where is" basis. Although reasonable efforts were made to confirm the accuracy of the information, Alberta Health Services does not make any representation or warranty, express, implied or statutory, as to the accuracy, reliability, completeness, applicability or fitness for a particular purpose of such information. This material is not a substitute for the advice of a qualified health professional. Alberta Health Services expressly disclaims all liability for the use of these materials, and for any claims, actions, demands or suits arising from such use. Document History Version Date Description of Revision Completed By / Revised By 1.1 July 2015 Completed document (2013) reformatted into Dr. Bullard / Carla new topic template Milligan 1.2 January Minor edits in the Rationale section and form 1 Dr. Bullard / Sarah 2016 info in general care section as well as addition Searle of CIWA-Ar Scoring Reference tool to appendix 1.3 May 2016 Minor edits made to working group Sarah Searle membership list 1.4 June Removed link to Center for Addiction and Dr. Bullard / Sarah 2017 Mental Health assessment and documentation Searle form on pg. 35. Documentation requirements will continue as per local practice at this time. -
Ethylene Glycol
NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Ethylene Glycol January 2004 NIH Publication No. 04-4481 Table of Contents Preface .............................................................................................................................................v Introduction .................................................................................................................................... vi NTP Brief on Ethylene Glycol .........................................................................................................1 References ........................................................................................................................................4 Appendix I. NTP-CERHR Ethylene Glycol / Propylene Glycol Expert Panel Preface ..............................................................................................................................I-1 Expert Panel ......................................................................................................................I-2 Appendix II. Expert Panel Report on Ethylene Glycol ............................................................... II-i Table of Contents ........................................................................................................... II-iii Abbreviations ...................................................................................................................II-v List of Tables ............................................................................................................... -
Severe Metabolic Acidosis in a Patient with an Extreme Hyperglycaemic Hyperosmolar State: How to Manage? Marloes B
Clinical Case Reports and Reviews Case Study ISSN: 2059-0393 Severe metabolic acidosis in a patient with an extreme hyperglycaemic hyperosmolar state: how to manage? Marloes B. Haak, Susanne van Santen and Johannes G. van der Hoeven* Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, the Netherlands Abstract Hyperglycaemic hyperosmolar state (HHS) and diabetic ketoacidosis (DKA) are often accompanied by severe metabolic and electrolyte disorders. Analysis and treatment of these disorders can be challenging for clinicians. In this paper, we aimed to discuss the most important steps and pitfalls in analyzing and treating a case with extreme metabolic disarrangements as a consequence of an HHS. Electrolyte disturbances due to fluid shifts and water deficits may result in potentially dangerous hypernatriema and hyperosmolality. In addition, acid-base disorders often co-occur and several approaches have been advocated to assess the acid-base disorder by integration of the principles of mass balance and electroneutrality. Based on the case vignette, four explanatory methods are discussed: the traditional bicarbonate-centered method of Henderson-Hasselbalch, the strong ion model of Stewart, and its modifications ‘Stewart at the bedside’ by Magder and the simplified Fencl-Stewart approach. The four methods were compared and tested for their bedside usefulness. All approaches gave good insight in the metabolic disarrangements of the presented case. However, we found the traditional method of Henderson-Hasselbalch and ‘Stewart at the bedside’ by Magder most explanatory and practical to guide treatment of the electrolyte disturbances and in exploring the acid-base disorder of the presented case. Introduction This is accompanied by changes in pCO2 and bicarbonate (HCO₃ ) levels, depending on the cause of the acid-base disorder. -
Toxicology and Environmental Teaching Tue 1St Oct 2019
TOXICOLOGY AND ENVIRONMENTAL TEACHING TUE 1ST OCT 2019 CASE ONE The ambulance bring in a 50 year old woman who has been found confused at her home by friends. There is no history available, but she was last seen well around dinner yesterday. She has no known past history and her medications are unknown. Initial Obs: - GCS M 5, E4, V4 pupils large and reactive - SBP 110 - HR 120 - Sats 99% o/a - Afebrile - BSL 8 1. She is confused and denies any ingestion or overdose. She dose state she only took some sleeping medication. What investigations would you do and how would you manage her presentation? Look up NHI: prior hx, community dispensing etc Investigations: Bloods, VBG, ECG Consider differential diagnoses : sepsis, trauma, metabolic 2. You note a community dispensing for 60 x 20mg amitriptyline tablets a few days ago. Her ECG and VBG are shown, please describe and discuss the findings: Potential toxic dose > 10mg/kg onset, toxicity usually rapid onset in 1- 2hrs VBG pH 7.35 PCO2 4.0 HCO3 15 Na 143 K 4.2 Lactate 3.5 - Sinus tachycardia with first-degree AV block (P waves hidden in the T waves, best seen in V1-2). - Broad QRS complexes. - Positive R’ wave in aVR. ECG Features of Sodium-Channel Blockade Interventricular conduction delay — QRS > 100 ms in lead II Right axis deviation of the terminal QRS: o Terminal R wave > 3 mm in aVR o R/S ratio > 0.7 in aVR Patients with tricyclic overdose will also usually demonstrate sinus tachycardia secondary to muscarinic (M1) receptor blockade. -
The Effects of Ethanol on Ketone Body Metabolism of Fasted Rats Henry S
Yale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 1975 The effects of ethanol on ketone body metabolism of fasted rats Henry S. Cabin Yale University Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl Recommended Citation Cabin, Henry S., "The effects of ethanol on ketone body metabolism of fasted rats" (1975). Yale Medicine Thesis Digital Library. 2432. http://elischolar.library.yale.edu/ymtdl/2432 This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information, please contact [email protected]. YALE MEDICAL LIBRARY YALE MEDICAL LIBRARY Digitized by the Internet Archive in 2017 with funding from The National Endowment for the Humanities and the Arcadia Fund https://archive.org/details/effectsofethanolOOcabi The Effects of Ethanol on Ketone Body Metabolism of Fasted Rats by Henry S, Cabin B.A. University of Pennsylvania, 1971 Presented in partial fulfillment of the requirements for the degree of Doctor of Medicine, Yale University School of Medicine -March, 1975- ACKNOWLEDGEMENTS To Dr. Felig- who.has guided me through this research project from its inception, and for whom I have the highest esteem as a teacher, physician and human being. To Rosa, Bill and Andrea- without whose support and assistance this project would never have come to fruition. -
Trihalomethanes/MTBE/Nitromethane Lab Procedure Manual
Laboratory Procedure Manual Analyte: Trihalomethanes/MTBE/Nitromethane Matrix: Whole Blood Method: Solid Phase Microextraction with GC Separation/High Resolution MS Method No: 2101.01 Revised: April 30, 2015 As performed by: Tobacco & Volatiles Branch Division of Laboratory Sciences National Center for Environmental Health Contact: Dr. Ben Blount Phone: 770-488-7894 Fax: 770-488-0181 Email: [email protected] James L. Pirkle, M.D., Ph.D. Director, Division of Laboratory Sciences Important Information for Users The Centers for Disease Control and Prevention (CDC) periodically refines these laboratory methods. It is the responsibility of the user to contact the person listed on the title page of each write-up before using the analytical method to find out whether any changes have been made and what revisions, if any, have been incorporated. THMs & MTBE VOCs in Blood DLS Method Code: 2101.01 National Center for Health Staistics 2 This document details the Lab Protocol for testing the items listed in the following table Data File Name Variable Name SAS Label LBXVBF Blood Bromoform (pg/mL) LBXVBM Blood Bromodichloromethane (pg/mL) VOCMWB_F LBXVCF Blood Chloroform (pg/mL) LBXVCM Blood Dibromochloromethane (pg/mL) LBXVME Blood MTBE (pg/mL) LBXVNM Blood Nitromethane (pg/mL) THMs & MTBE VOCs in Blood DLS Method Code: 2101.01 National Center for Health Staistics 3 1. Clinical Relevance and Summary of Test Principle a. Clinical Relevance The prevalence of disinfection by-products in drinking water supplies has raised concerns about possible adverse health effects from chronic exposure to these potentially carcinogenic compounds. To support studies exploring the relation between exposure to trihalomethanes (THMs), nitromethane (NM: biomarker for halonitromethanes), methyl tert-butyl ether (MTBE) and adverse health effects, an automated analytical method was developed using capillary gas chromatography (GC) and high-resolution mass spectrometry (MS) with selected ion mass detection and isotope-dilution techniques. -
Alcoholic Ketoacidosis
Alcoholic Ketoacidosis: Mind The Gap, Give Them What They Need Brendan Innes BS, Stephanie Carreiro MD University of Massachusetts Medical School, Department of Emergency Medicine Introduction Differential Diagnosis Case Discussion Pancreatitis, Alcohol induced gastritis, Alcohol withdrawal, Diagnostic Criteria for Alcoholic Ketoacidosis2,3 • Patients with alcohol use disorder commonly present to the ED Alcohol induced hepatitis, Acute Kidney Injury, Sepsis, Binge drinking ending in nausea, vomiting, and decreased intake critically ill due to a myriad of underlying pathologies. Metabolic abnormality (Alcoholic ketoacidosis), Acute coronary syndrome, Pulmonary embolism Wide anion gap metabolic acidosis without alternate explanation • Alcoholic ketoacidosis (AKA) should be considered in anyone Clinical Data Positive serum/urine ketones with prolonged and/or binge consumption of alcohol. Low, normal, or slightly elevated serum glucose Anion Gap 36 130 83 27 Urinalysis Core Emergency Medicine Principles • Diagnosis and proper treatment results in rapid correction of 167 Lactate 1.9 5 11 1.9 Protein 2+ • Treatment for AKA requires glucose administration, thiamine underlying metabolic derangements often followed by rapid Salicylate, ethylene glycol, Ketones 3+ supplementation, and volume repletion. methanol not detected Urobilinogen + • D5 NS IV until rehydrated, D5 1/2NS for maintenance. clinical improvement. 16.6 Digoxin: 0.3 ng/mL 17.2 241 RBCs 5/hpf • Thiamine 100 mg IV before glucose. • Failure to make the diagnosis can result in shock, hypokalemia, 49.3 PT/INR: >120/>11 Hyaline casts 21 • Supplement electrolytes PRN. VBG: pH 7.34, pCO2 25 • Continue treatment until anion gap closes, oral intake tolerated. 90% PMNs /hpf hypoglycemia, and acidosis. • Consider other causes of anion gap if gap does not close with Neutrophils 15.6x103/µL BNP: 66 pc/mL UTox: caffeine Trop: 0.1 ng/mL treatment Lipase: 13 U/L Case Description EKG: sinus tach • Consider sodium bicarbonate if despite treatment pH < 7.0. -
Diabetic Ketoacidosis
PRIMER Diabetic ketoacidosis Ketan K. Dhatariya1,2, Nicole S. Glaser3, Ethel Codner4 and Guillermo E. Umpierrez5 ✉ Abstract | Diabetic ketoacidosis (DKA) is the most common acute hyperglycaemic emergency in people with diabetes mellitus. A diagnosis of DKA is confirmed when all of the three criteria are present — ‘D’, either elevated blood glucose levels or a family history of diabetes mellitus; ‘K’, the presence of high urinary or blood ketoacids; and ‘A’, a high anion gap metabolic acidosis. Early diagnosis and management are paramount to improve patient outcomes. The mainstays of treatment include restoration of circulating volume, insulin therapy , electrolyte replacement and treatment of any underlying precipitating event. Without optimal treatment, DKA remains a condition with appreciable, although largely preventable, morbidity and mortality. In this Primer, we discuss the epidemiology , pathogenesis, risk factors and diagnosis of DKA and provide practical recommendations for the management of DKA in adults and children. Circulatory volume Diabetic ketoacidosis (DKA) is the most common acute acid decarboxylase and protein tyrosine phosphatase depletion hyperglycaemic emergency in people with diabetes mel- autoantibodies, as those who present with hyperosmo- A reduction in intravascular litus. DKA is the consequence of an absolute (that is, lar hyperglycaemic state (HHS), and their β-cell func- and/or extracellular fluid total absence of) or relative (that is, levels insufficient tion recovers with restoration of insulin secretion quickly volume, such that there may 2 be an inability to adequately to supress ketone production) lack of insulin and con- after treatment . Thus, individuals with ketosis-prone perfuse tissue. comitant elevation of counter-regulatory hormones, T2DM can often go back to oral glucose-lowering medi- usually resulting in the triad of hyperglycaemia, met- cation without the need for continuing insulin therapy. -
Inhalant Abuse Pediatric Care
CLINICAL REPORT Guidance for the Clinician in Rendering Inhalant Abuse Pediatric Care Janet F. Williams, MD, Michael Storck, MD, and the Committee on Substance Abuse and Committee on Native American Child Health ABSTRACT Inhalant abuse is the intentional inhalation of a volatile substance for the purpose of achieving an altered mental state. As an important, yet-underrecognized form of substance abuse, inhalant abuse crosses all demographic, ethnic, and socioeco- nomic boundaries, causing significant morbidity and mortality in school-aged and older children. This clinical report reviews key aspects of inhalant abuse, empha- sizes the need for greater awareness, and offers advice regarding the pediatrician’s role in the prevention and management of this substance abuse problem. TYPES OF CHEMICALS AND PRODUCTS ABUSED The term “inhalant” encompasses a wide range of pharmacologically diverse substances that readily vaporize. Most other substances of abuse are classified by grouping together substances that share a specific central nervous system action or perceived psychoactive effect, but inhalant substances that are abused are grouped by having a common route of drug use. Inhalant abuse, sometimes referred to as solvent or volatile substance abuse, can be better understood when the expansive list of inhalants is classified into 3 groups on the basis of what is currently known pharmacologically: group I includes volatile solvents, fuels, and anesthetics; group II includes nitrous oxide; and group III includes volatile alkyl nitrites (Table 1). This classification is also consistent with reported differences in user populations, patterns of abuse, and associated problems seen clinically.1–3 Drugs that do not www.pediatrics.org/cgi/doi/10.1542/ readily vaporize at room temperature, such as cocaine, heroin, nicotine, or alcohol, peds.2007-0470 can also be abused through inhalation, but characteristic pharmacologic properties doi:10.1542/peds.2007-0470 distinguish these substances from inhalants. -
TOXICOLOGY and EXPOSURE GUIDELINES ______(For Assistance, Please Contact EHS at (402) 472-4925, Or Visit Our Web Site At
(Revised 1/03) TOXICOLOGY AND EXPOSURE GUIDELINES ______________________________________________________________________ (For assistance, please contact EHS at (402) 472-4925, or visit our web site at http://ehs.unl.edu/) "All substances are poisons; there is none which is not a poison. The right dose differentiates a poison and a remedy." This early observation concerning the toxicity of chemicals was made by Paracelsus (1493- 1541). The classic connotation of toxicology was "the science of poisons." Since that time, the science has expanded to encompass several disciplines. Toxicology is the study of the interaction between chemical agents and biological systems. While the subject of toxicology is quite complex, it is necessary to understand the basic concepts in order to make logical decisions concerning the protection of personnel from toxic injuries. Toxicity can be defined as the relative ability of a substance to cause adverse effects in living organisms. This "relative ability is dependent upon several conditions. As Paracelsus suggests, the quantity or the dose of the substance determines whether the effects of the chemical are toxic, nontoxic or beneficial. In addition to dose, other factors may also influence the toxicity of the compound such as the route of entry, duration and frequency of exposure, variations between different species (interspecies) and variations among members of the same species (intraspecies). To apply these principles to hazardous materials response, the routes by which chemicals enter the human body will be considered first. Knowledge of these routes will support the selection of personal protective equipment and the development of safety plans. The second section deals with dose-response relationships.